The Evidence Based Rheumatology Podcast

E22: Ustekinumab for Giant Cell Arteritis

Quick episode today on a small prospective trial on ustekinumab for giant cell arteritis.  Papers can all be found here! 

E21: ACE Levels for Sarcoidosis

This weeks episode discusses the utility of the ACE level in sarcoidosis. Lots of LRs, sensitivty, and specificities today! 

E20: Rituxan vs. Cytoxan for AAV - The RAVE Trial

This week we discuss the pivotal RAVE trial in all it's rituxan justifying glory.  I've also added a handy Box link with all of the papers I've discussed, so check it out if you'd like to follow along! Link here.

E19: Clinical Utility of a Positive ANA

Quick podcast this week on the utility of an ANA.  It's a frequent reason for referral (17% in this series) to rheumatology offices and this is a useful paper for context. Find the paper itself here.

E18: Triple Therapy for Catastrophic Antiphospholipid Syndrome

A recent retrospective study on a rare condition - catastrophic antiphospholipid syndrome - caught my eye in the Journal of Rheumatology this week.  I thought it would be a good opportunity to talk about unmeasured confounding and introduce a rare condition that new fellows need to know about.  Find the paper itself here. 

E17: Steroids and the Risk of Scleroderma Renal Crisis

Short but impactful paper this week on the association between steroids and scleroderma renal crisis.  Find the original paper here.

E16: Tocilizumab in Giant-Cell Arteritis - GIACTA

Getting back to our usual format, this week we'll discuss the GIACTA trial, which compared various schedules of tocilizumab to various schedules of placebo and prednisone.  It's an important trial that has changed the face of GCA and will be a refreshing RCT to discuss before we dive back into garbagey data next week.  

E15: The Ribosomal P Isn't Useful in NPSLE

Welcome back! This week we're doing something a little different and discussing a few important studies on the ribosomal P in neuropsychiatric SLE.  We also have theme music!  Let me know what you think about both on twitter @EBRheum. 

E14: Cardiovascular Safety of Febuxostat

Today we'll discuss an important trial on febuxostat (ulloric), which raises important concerns about its safety from a cardiovascular perspective. Be sure to tune in to the #RheumJC discussion that will be happening this Thursday! 

E13: Withdrawing HCQ in SLE

Short podcast today on an old RCT addressing the utility of hydroxychloroquine (plaquenil) in lupus. It's an oldie but goodie and one that I enjoyed talking about.